NORTHERN TRUST CORP - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 159 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$298,563
+12.5%
311,003
-12.1%
0.00%
Q1 2023$265,428
+120.3%
353,904
+8.3%
0.00%
Q4 2022$120,465
-14.6%
326,906
-0.4%
0.00%
Q3 2022$141,000
-44.7%
328,278
+0.2%
0.00%
Q2 2022$255,000
-86.6%
327,751
-77.7%
0.00%
Q1 2022$1,899,000
-11.6%
1,472,567
-12.9%
0.00%
Q4 2021$2,147,000
-46.3%
1,691,151
-7.7%
0.00%
-100.0%
Q3 2021$3,995,000
-42.7%
1,832,302
-1.5%
0.00%0.0%
Q2 2021$6,977,000
+31.0%
1,860,874
+13.9%
0.00%0.0%
Q1 2021$5,325,000
-8.0%
1,633,550
-3.8%
0.00%0.0%
Q4 2020$5,790,000
-16.7%
1,697,658
-0.3%
0.00%
-50.0%
Q3 2020$6,950,000
+42.2%
1,703,349
+17.8%
0.00%
+100.0%
Q2 2020$4,886,000
+43.7%
1,445,792
-0.9%
0.00%0.0%
Q1 2020$3,400,000
-36.7%
1,459,309
-1.2%
0.00%0.0%
Q4 2019$5,373,000
-55.2%
1,476,441
+2.2%
0.00%
-66.7%
Q3 2019$11,981,000
+7.8%
1,444,419
+11.9%
0.00%0.0%
Q2 2019$11,112,000
-17.8%
1,290,560
+2.1%
0.00%0.0%
Q1 2019$13,516,000
+23.0%
1,264,309
+0.7%
0.00%0.0%
Q4 2018$10,986,000
-50.7%
1,255,410
-5.3%
0.00%
-40.0%
Q3 2018$22,265,000
-16.0%
1,325,256
+4.9%
0.01%
-28.6%
Q2 2018$26,492,000
+52.7%
1,263,899
+17.2%
0.01%
+40.0%
Q1 2018$17,345,000
-14.7%
1,078,050
+0.5%
0.01%0.0%
Q4 2017$20,332,000
+46.4%
1,072,970
+8.7%
0.01%
+25.0%
Q3 2017$13,891,000
+91.0%
987,290
+1.2%
0.00%
+100.0%
Q2 2017$7,271,000
+12.0%
975,977
-2.3%
0.00%0.0%
Q1 2017$6,494,000
+56.5%
999,075
+6.6%
0.00%
+100.0%
Q4 2016$4,150,000
+2.7%
936,942
+8.3%
0.00%0.0%
Q3 2016$4,041,000
-19.8%
865,342
+12.8%
0.00%
-50.0%
Q2 2016$5,041,000
+1.8%
767,398
-1.4%
0.00%0.0%
Q1 2016$4,952,000
+11.2%
778,462
+5.5%
0.00%
+100.0%
Q4 2015$4,452,000
+4.9%
738,209
+4.0%
0.00%0.0%
Q3 2015$4,246,000
-12.6%
710,093
-0.1%
0.00%0.0%
Q2 2015$4,860,000
+11.5%
710,516
-1.0%
0.00%0.0%
Q1 2015$4,359,000
-13.4%
718,050
-1.1%
0.00%
-50.0%
Q4 2014$5,031,000
-17.1%
725,979
-2.6%
0.00%0.0%
Q3 2014$6,067,000
-0.5%
745,340
-0.7%
0.00%0.0%
Q2 2014$6,099,000
-8.8%
750,226
-12.0%
0.00%0.0%
Q1 2014$6,684,000
-17.6%
852,645
-7.0%
0.00%
-33.3%
Q4 2013$8,115,000
-1.0%
916,983
-6.3%
0.00%0.0%
Q3 2013$8,200,000
+18.1%
978,494
+5.1%
0.00%0.0%
Q2 2013$6,945,000930,9630.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Piermont Capital Management Inc. 312,842$2,033,0000.48%
BARD ASSOCIATES INC 648,525$4,215,0000.39%
Sonora Investment Management, LLC 233,295$1,516,418,0000.30%
Nine Chapters Capital Management LLC 32,400$211,0000.28%
Alambic Investment Management, L.P. 287,601$1,869,0000.23%
Granite Investment Partners, LLC 201,221$1,308,0000.09%
Renaissance Technologies 5,679,800$36,919,0000.05%
PDT Partners, LLC 123,200$801,0000.04%
ClariVest Asset Management LLC 242,050$1,573,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 315,934$2,054,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders